Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This entity is a non-coding RNA transcript antisense to the TRPV6 gene, identified as AC245427.1/ENSG00000224970. It is expressed in various tissues including tonsil, and annotated primarily by high-throughput sequencing projects[1]. Its precise biological function is unknown, but as an antisense RNA, it may regulate the expression of TRPV6, a gene encoding an epithelial calcium channel involved in calcium absorption and associated with numerous physiological and pathological processes[4]. There is no evidence that this transcript encodes a protein or acts as a direct drug target, nor are there documented roles in disease, mechanisms of drug action, or relevance as a biomarker[2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Novel transcript, antisense to TRPV6 (AC245427.1).